Volume 13, Number 1—January 2007
Research
Tickborne Relapsing Fever Diagnosis Obscured by Malaria, Togo
Table 2
Region, age group, y | Seropositive for relapsing fever Borrelia,* no. positive/no. tested (%) | Borrelia in blood,† no. positive/no. tested (%) | Infected with B. crocidurae,‡ no. positive/no. tested (%) | Infected with B. duttonii,‡ no. positive/ no. tested (%) |
---|---|---|---|---|
Northern | ||||
0–4 | 6/60 (10) | 4 (6.7) | 3 (5) | 1 (1.7) |
5–14 | 3/30 (10) | 4 (13.3) | 3 (10) | 1 (3.3) |
Total | 9/90 (10) | 8 (8.8) | 6 (6.7) | 2 (2.2) |
Southern | ||||
0–4 | 2/16 (12.5) | 1 (6.3) | 1 (6.3) | 0 |
5–14 | 3/35 (8.6) | 2 (5.7) | 2 (5.7) | 0 |
Total | 5/51 (9.8) | 3 (5.9) | 3 (5.9) | 0 |
15–24 | 7/43 (16.3) | 3 (7) | 3 (7) | 0 |
>25 | 9/55 (16.4) | 7 (12.7) | 7 (12.7) | 0 |
Total for adults | 16/98 (16.3) | 10 (10.2) | 10 (10.2) | 0 |
Total | 21/149 (14.1) | 13 (8.7) | 13 (8.7) | 0 |
All | 30/239 (12.6) | 21 (8.8) | 19 (7.9) | 2 (1.2) |
*Determined by ELISA for glycerophosphodiester phosphodiesterase antigen.
†Determined by 16S rRNA gene PCR amplification from blood of patients with high ELISA values divided by all ELISA- tested patients.
‡Determined by genomic sequence of 16S rRNA in blood samples.
Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.